Azetidine derivative
25-05-2021 дата публикации
Номер:
US0011014943B2
Автор: Jian Xiong, CHENG XIE, Kevin X Chen, Xiongbin XU, Xuejin Zhang, Zhen Gong, Jian Li, Shuhui Chen, Aiming Zhang, Zhulian JIANG, Xiquan Zhang, Xin Tian, XIONG JIAN, Xie Cheng, CHEN KEVIN X, XU XIONGBIN, Zhang Xuejin, GONG ZHEN, LI JIAN, CHEN SHUHUI, ZHANG AIMING, JIANG ZHULIAN, ZHANG XIQUAN, TIAN XIN, Xiong, Jian, Xie, Cheng, Chen, Kevin X, XU, Xiongbin, ZHANG, Xuejin, GONG, Zhen, Li, Jian, Chen, Shuhui, Zhang, Aiming, JIANG, Zhulian, Zhang, Xiquan, TIAN, Xin
Принадлежит: CHIA TAI TIANQING PHARMACEUTICAL GROUP GO., LTD., CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD, CHIA TAI TIANQING PHARMACEUTICAL GROUP GO LTD, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Контакты:
Номер заявки: 82-92-1648
Дата заявки: 28-02-2018
CPC - классификация
AA6A61A61KA61K3A61K31A61K31/A61K31/6A61K31/69A61PA61P3A61P35A61P35/A61P35/0A61P35/00CC0C07C07FC07F5C07F5/C07F5/0C07F5/02C07F5/025IPC - классификация
AA6A61A61KA61K3A61K31A61K31/A61K31/6A61K31/69A61PA61P3A61P35A61P35/A61P35/0A61P35/00A61P35/02A61P35/04CC0C07C07FC07F5C07F5/C07F5/0C07F5/02Цитирование НПИ
Dorsey, et al; Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer; J. Med. Chem. (2008); 51; 1068-1072.Dou, Q.P. et al; Overview of Proteasome Inhibitor-Based Anti-Cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors Versus Future Generation Inhibitors of Ubiquitin-Proteasome System; Current Cancer Drug Targets; 14(6), Dec. 31, 2014, pp. 517-536.
European Patent Office; Communication—Supplementary European Search Report; EP Appl. No. 18760796.5; dated Nov. 11, 2020; (6 pgs.).
Ruggeri, B., et al; The Development and Pharmacology of Proteasome Inhibitors for the Management and Treatment of Cancer; Advances in Pharmacology (San Diego, CA, US); vol. 57, Dec. 31, 2009; pp. 91-135.
State Intellectual Property Office of the P.R. China; International Search Report of International Application No. PCT/CN2018/077583, dated Jun. 1, 2018.